Highlights

[PNEPCB] QoQ Quarter Result on 2020-06-30 [#1]

Stock [PNEPCB]: PNE PCB BHD
Announcement Date 26-Aug-2020
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2021
Quarter 30-Jun-2020  [#1]
Profit Trend QoQ -     53.54%    YoY -     54.47%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 16,070 13,335 17,147 16,554 18,081 17,808 20,042 -13.70%
  QoQ % 20.51% -22.23% 3.58% -8.45% 1.53% -11.15% -
  Horiz. % 80.18% 66.54% 85.56% 82.60% 90.22% 88.85% 100.00%
PBT -1,228 -750 -673 -2,093 -2,680 -3,609 -1,816 -22.98%
  QoQ % -63.73% -11.44% 67.85% 21.90% 25.74% -98.73% -
  Horiz. % 67.62% 41.30% 37.06% 115.25% 147.58% 198.73% 100.00%
Tax 0 -1,893 -13 -14 -17 -10 -23 -
  QoQ % 0.00% -14,461.54% 7.14% 17.65% -70.00% 56.52% -
  Horiz. % -0.00% 8,230.43% 56.52% 60.87% 73.91% 43.48% 100.00%
NP -1,228 -2,643 -686 -2,107 -2,697 -3,619 -1,839 -23.62%
  QoQ % 53.54% -285.28% 67.44% 21.88% 25.48% -96.79% -
  Horiz. % 66.78% 143.72% 37.30% 114.57% 146.66% 196.79% 100.00%
NP to SH -1,228 -2,643 -686 -2,107 -2,697 -3,619 -1,839 -23.62%
  QoQ % 53.54% -285.28% 67.44% 21.88% 25.48% -96.79% -
  Horiz. % 66.78% 143.72% 37.30% 114.57% 146.66% 196.79% 100.00%
Tax Rate - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Total Cost 17,298 15,978 17,833 18,661 20,778 21,427 21,881 -14.51%
  QoQ % 8.26% -10.40% -4.44% -10.19% -3.03% -2.07% -
  Horiz. % 79.05% 73.02% 81.50% 85.28% 94.96% 97.93% 100.00%
Net Worth 54,379 56,543 57,858 59,173 60,488 64,433 67,063 -13.06%
  QoQ % -3.83% -2.27% -2.22% -2.17% -6.12% -3.92% -
  Horiz. % 81.09% 84.31% 86.27% 88.24% 90.20% 96.08% 100.00%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div - - - - - - - -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 54,379 56,543 57,858 59,173 60,488 64,433 67,063 -13.06%
  QoQ % -3.83% -2.27% -2.22% -2.17% -6.12% -3.92% -
  Horiz. % 81.09% 84.31% 86.27% 88.24% 90.20% 96.08% 100.00%
NOSH 132,633 131,497 131,497 131,497 131,497 131,497 131,497 0.58%
  QoQ % 0.86% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.86% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -7.64 % -19.82 % -4.00 % -12.73 % -14.92 % -20.32 % -9.18 % -11.53%
  QoQ % 61.45% -395.50% 68.58% 14.68% 26.57% -121.35% -
  Horiz. % 83.22% 215.90% 43.57% 138.67% 162.53% 221.35% 100.00%
ROE -2.26 % -4.67 % -1.19 % -3.56 % -4.46 % -5.62 % -2.74 % -12.06%
  QoQ % 51.61% -292.44% 66.57% 20.18% 20.64% -105.11% -
  Horiz. % 82.48% 170.44% 43.43% 129.93% 162.77% 205.11% 100.00%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 12.12 10.14 13.04 12.59 13.75 13.54 15.24 -14.17%
  QoQ % 19.53% -22.24% 3.57% -8.44% 1.55% -11.15% -
  Horiz. % 79.53% 66.54% 85.56% 82.61% 90.22% 88.85% 100.00%
EPS -0.93 -2.01 -0.52 -1.60 -2.05 -2.75 -1.40 -23.89%
  QoQ % 53.73% -286.54% 67.50% 21.95% 25.45% -96.43% -
  Horiz. % 66.43% 143.57% 37.14% 114.29% 146.43% 196.43% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.4100 0.4300 0.4400 0.4500 0.4600 0.4900 0.5100 -13.55%
  QoQ % -4.65% -2.27% -2.22% -2.17% -6.12% -3.92% -
  Horiz. % 80.39% 84.31% 86.27% 88.24% 90.20% 96.08% 100.00%
Adjusted Per Share Value based on latest NOSH - 176,538
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 9.10 7.55 9.71 9.38 10.24 10.09 11.35 -13.71%
  QoQ % 20.53% -22.25% 3.52% -8.40% 1.49% -11.10% -
  Horiz. % 80.18% 66.52% 85.55% 82.64% 90.22% 88.90% 100.00%
EPS -0.70 -1.50 -0.39 -1.19 -1.53 -2.05 -1.04 -23.22%
  QoQ % 53.33% -284.62% 67.23% 22.22% 25.37% -97.12% -
  Horiz. % 67.31% 144.23% 37.50% 114.42% 147.12% 197.12% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.3080 0.3203 0.3277 0.3352 0.3426 0.3650 0.3799 -13.06%
  QoQ % -3.84% -2.26% -2.24% -2.16% -6.14% -3.92% -
  Horiz. % 81.07% 84.31% 86.26% 88.23% 90.18% 96.08% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 1.0300 0.4300 0.4950 0.5350 0.4850 0.5200 0.5700 -
P/RPS 8.50 4.24 3.80 4.25 3.53 3.84 3.74 72.95%
  QoQ % 100.47% 11.58% -10.59% 20.40% -8.07% 2.67% -
  Horiz. % 227.27% 113.37% 101.60% 113.64% 94.39% 102.67% 100.00%
P/EPS -111.25 -21.39 -94.88 -33.39 -23.65 -18.89 -40.76 95.42%
  QoQ % -420.10% 77.46% -184.16% -41.18% -25.20% 53.66% -
  Horiz. % 272.94% 52.48% 232.78% 81.92% 58.02% 46.34% 100.00%
EY -0.90 -4.67 -1.05 -2.99 -4.23 -5.29 -2.45 -48.74%
  QoQ % 80.73% -344.76% 64.88% 29.31% 20.04% -115.92% -
  Horiz. % 36.73% 190.61% 42.86% 122.04% 172.65% 215.92% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 2.51 1.00 1.13 1.19 1.05 1.06 1.12 71.34%
  QoQ % 151.00% -11.50% -5.04% 13.33% -0.94% -5.36% -
  Horiz. % 224.11% 89.29% 100.89% 106.25% 93.75% 94.64% 100.00%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 26/08/20 29/06/20 26/02/20 25/11/19 29/08/19 28/05/19 27/02/19 -
Price 1.1000 1.0200 0.4650 0.5600 0.5450 0.4800 0.5350 -
P/RPS 9.08 10.06 3.57 4.45 3.96 3.54 3.51 88.55%
  QoQ % -9.74% 181.79% -19.78% 12.37% 11.86% 0.85% -
  Horiz. % 258.69% 286.61% 101.71% 126.78% 112.82% 100.85% 100.00%
P/EPS -118.81 -50.75 -89.13 -34.95 -26.57 -17.44 -38.25 113.03%
  QoQ % -134.11% 43.06% -155.02% -31.54% -52.35% 54.41% -
  Horiz. % 310.61% 132.68% 233.02% 91.37% 69.46% 45.59% 100.00%
EY -0.84 -1.97 -1.12 -2.86 -3.76 -5.73 -2.61 -53.07%
  QoQ % 57.36% -75.89% 60.84% 23.94% 34.38% -119.54% -
  Horiz. % 32.18% 75.48% 42.91% 109.58% 144.06% 219.54% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 2.68 2.37 1.06 1.24 1.18 0.98 1.05 86.87%
  QoQ % 13.08% 123.58% -14.52% 5.08% 20.41% -6.67% -
  Horiz. % 255.24% 225.71% 100.95% 118.10% 112.38% 93.33% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS